Chloroquine, hydroxychloroquine and azithromycin are being used to treat and prevent COVID-19 despite weak evidence for effectiveness, and physicians and patients should be aware of the drugs' potentially serious adverse ...
Apr 8, 2020
0
112
Researchers from the University of California, Irvine have conducted a statistical analysis that predicts more than 70,000 heart attacks, strokes and other adverse cardiovascular events could be prevented each year in the ...
Mar 25, 2020
0
138
A new systematic review and meta-analysis showed a small but significant reduction in subjective pain scores for cannabinoid treatment compared to placebo in patients experiencing acute pain. No increase in serious adverse ...
Mar 23, 2020
0
2
A new paper in Nutrition Reviews finds that intake of the flavonoid quercetin can greatly reduce high blood pressure in patients suffering from cardiovascular disease.
Jan 15, 2020
0
5
Physicians should prescribe testosterone for men with age-related low testosterone only to treat sexual dysfunction, the American College of Physicians (ACP) says in a new evidence-based clinical practice guideline published ...
Jan 7, 2020
0
2
(HealthDay)—Recall of a cardiac resynchronization therapy pacemaker, which occurred in November 2015, was delayed unnecessarily, according to a report published online Dec. 20 in JAMA Internal Medicine.
Dec 27, 2019
0
2
Treating high-risk heart patients with a single, high dose of radiation therapy can dramatically reduce episodes of rapid, abnormal heartbeats for more than two years, offering hope to patients who have exhausted other treatment ...
Sep 26, 2019
0
1
After years of generalized theories and hypothesis, research has finally pinpointed certain aspects of childhood experience linked to people living longer.
Sep 18, 2019
0
6
Adverse drug events could be avoided by sharing patients' medication histories and previous harmful medication exposures among various health-care facilities. That's one of the key findings of a study published today in CMAJ ...
Jul 19, 2019
0
1
As advances in the treatment of non-small cell lung cancer (NSCLC) extend patients' lives, more of these patients are facing a different threat: adverse cardiovascular events, such as heart attacks and heart failure. A new ...
Jun 10, 2019
0
3
